VERTEX PHARMACEUTICALS INC / MA Comprehensive Income 2009-2026 | VRTX
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is VERTEX PHARMACEUTICALS INC / MA's current comprehensive income?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual comprehensive income for 2025 was $3.81B, a 1068.11% increase from 2024. VERTEX PHARMACEUTICALS INC / MA comprehensive income for the quarter ending March 31, 2026 was $1.07B.
What was VERTEX PHARMACEUTICALS INC / MA's comprehensive income in 2024?
VERTEX PHARMACEUTICALS INC / MA annual comprehensive income for 2024 was $-393.5M, a 110.92% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's comprehensive income in 2023?
VERTEX PHARMACEUTICALS INC / MA annual comprehensive income for 2023 was $3.60B, a 9.00% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year comprehensive income CAGR?
VERTEX PHARMACEUTICALS INC / MA comprehensive income grew at a compound annual growth rate (CAGR) of 7.57% from FY2020 to FY2025, going from $2.65B to $3.81B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.81B | +1068.1% | 10-K |
| FY2024 | $-393.5M | -110.9% | 10-K |
| FY2023 | $3.60B | +9.0% | 10-K |
| FY2022 | $3.31B | +36.3% | 10-K |
| FY2021 | $2.43B | -8.3% | 10-K |
| FY2020 | $2.65B | +125.3% | 10-K |
| FY2019 | $1.17B | -45.0% | 10-K |
| FY2018 | $2.13B | +824.5% | 10-K |
| FY2017 | $230.7M | +348.9% | 10-K |
| FY2016 | $-92.7M | +84.2% | 10-K |
| FY2015 | $-587.3M | +20.8% | 10-K |
| FY2014 | $-741.5M | -7.9% | 10-K |
| FY2013 | $-687.3M | -1257.5% | 10-K |
| FY2012 | $-50.6M | -222.9% | 10-K |
| FY2011 | $41.2M | +105.5% | 10-K |
| FY2010 | $-755.1M | -16.9% | 10-K |
| FY2009 | $-646.0M | - | 10-K |